Loading…

Prostaglandin E2 enhances Th17 responses via modulation of IL‐17 and IFN‐γ production by memory CD4+ T cells

The contribution of Th1 and Th17 cells in chronic inflammatory conditions leading to autoimmunity remains highly controversial. In inflamed tissues, production of prostaglandins by COX‐2 has been proposed to favor Th17 responses indirectly by increasing IL‐23 and blocking IL‐12 release from APC. We...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology 2009-05, Vol.39 (5), p.1301-1312
Main Authors: Napolitani, Giorgio, Acosta‐Rodriguez, Eva V., Lanzavecchia, Antonio, Sallusto, Federica
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The contribution of Th1 and Th17 cells in chronic inflammatory conditions leading to autoimmunity remains highly controversial. In inflamed tissues, production of prostaglandins by COX‐2 has been proposed to favor Th17 responses indirectly by increasing IL‐23 and blocking IL‐12 release from APC. We report here that prostaglandin E2 (PGE2) can directly modulate cytokine production by human memory CD4+ T cells. TCR triggering in the presence of PGE2 increased IL‐17 and reduced IFN‐γ production by freshly isolated memory T cells or T‐cell clones. PGE2 triggered the EP2 and EP4 receptors expressed on T cells leading to a rapid increase of retinoic‐acid‐related orphan receptor‐γt (ROR‐γt) and decrease of T‐cell‐specific T‐box transcription factor 21 (T‐bet) mRNA. Moreover, PGE2 promoted the selective enrichment of IL‐17‐producing cells by differentially modulating the proliferation of memory T‐cell subsets in vitro. Taken together our results indicate that T‐cell effector function is a direct target for PGE2 modulation and suggest a novel mechanism by which inhibitors of prostaglandin synthesis, such as COX‐2 inhibitors, exert their anti‐inflammatory effect.
ISSN:0014-2980
1521-4141
DOI:10.1002/eji.200838969